SBP Provides a Business Update and Files Report for Q3 2018
November 5, 2018
SBP Provides a Business Update and Files Report for Q3 2018
- Sun BioPharma, Inc. opens third site in Melbourne, Australia in Front-Line Combination Study of SBP-101 with Gemcitabine and nab-Paclitaxel for the Treatment of Patients with Metastatic Pancreatic Cancer
- Company announces leadership changes
- Results of new pancreatitis study presented at American Pancreatic Association meeting